ROR gamma t inhibitors(4SC/CRELUX)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameROR gamma t inhibitors(4SC/CRELUX)
Drug Alias Name4SC-X09 programROR gamma t inhibitors(4SC)SC-89732SC-92366
ClassificationSmall molecules
Mechanisms of ActionImmunomodulatorsApoptosis stimulantsNuclear receptor ROR-gamma antagonists
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator Companies4sc Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCRELUX Gmbh4SC Discovery Gmbh4sc Ag
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A